Indaptus Therapeutics logo

Indaptus Therapeutics Share Price Today

(NASDAQ: INDP)

Indaptus Therapeutics share price is $0.81 & ₹70.44 as on 6 Mar 2025, 2.30 'hrs' IST

$0.81

-0.01

(-0.98%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Indaptus Therapeutics share price in Dollar and Rupees. Guide to invest in Indaptus Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Indaptus Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Indaptus Therapeutics share price movements

  • Today's Low: $0.81
    Today's High: $0.83

    Day's Volatility :2.44%

  • 52 Weeks Low: $0.70
    52 Weeks High: $3.10

    52 Weeks Volatility :77.38%

Indaptus Therapeutics (INDP) Returns

PeriodIndaptus Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-15.42%
3.7%
0.0%
6 Months
-46.23%
-2.8%
0.0%
1 Year
-58.36%
2.5%
0.0%
3 Years
-78.91%
12.9%
-11.6%

Indaptus Therapeutics (INDP) Key Statistics

in dollars & INR

Previous Close
$0.82
Open
$0.815525
Today's High
$0.8303
Today's Low
$0.81
Market Capitalization
$11.6M
Today's Volume
$2.9K
52 Week High
$3.1
52 Week Low
$0.7012
Revenue TTM
$0.0
EBITDA
$-15.4M
Earnings Per Share (EPS)
$-1.78
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-139.6%

How to invest in Indaptus Therapeutics Stock (INDP) from India?

It is very easy for Indian residents to invest directly in Indaptus Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Indaptus Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Indaptus Therapeutics or INDP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Indaptus Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Indaptus Therapeutics shares which would translate to 1.074 fractional shares of Indaptus Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Indaptus Therapeutics, in just a few clicks!

Returns in Indaptus Therapeutics (INDP) for Indian investors in Rupees

The Indaptus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Indaptus Therapeutics investment value today

Current value as on today

₹46,487

Returns

₹53,513

(-53.51%)

Returns from Indaptus Therapeutics Stock

₹58,462 (-58.46%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Indaptus Therapeutics (INDP)

64%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Indaptus Therapeutics Stock from India on INDmoney has increased by 64% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Indaptus Therapeutics

  • Vanguard Group Inc

    2.13%

  • Investment House LLC

    0.83%

  • Geode Capital Management, LLC

    0.68%

  • Strategy Asset Managers LLC

    0.38%

  • Pine Valley Investments Ltd Liability Co

    0.37%

  • Renaissance Technologies Corp

    0.23%

Analyst Recommendation on Indaptus Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Indaptus Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Indaptus Therapeutics Stock (INDP)

What analysts predicted

Upside of 949.38%

Target:

$8.50

Current:

$0.81

Insights on Indaptus Therapeutics Stock (Ticker Symbol: INDP)

  • Price Movement

    In the last 7 days, INDP stock has moved up by 3.3%
  • INDP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 124.9%
  • INDP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 132.1%

Indaptus Therapeutics Technicals Summary

Sell

Neutral

Buy

Indaptus Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Indaptus Therapeutics (INDP) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Indaptus Therapeutics Inc logo
-11.45%
-46.23%
-58.36%
-78.91%
-95.79%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Indaptus Therapeutics Inc logo
NA
NA
NA
-1.79
-1.4
-0.74
NA
0.59
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Indaptus Therapeutics Inc logo
Buy
$11.6M
-95.79%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Indaptus Therapeutics

Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
Organization
Indaptus Therapeutics
Employees
7
CEO
Mr. Jeffrey A. Meckler J.D.
Industry
Healthcare

Management People of Indaptus Therapeutics

NameTitle
Mr. Jeffrey A. Meckler J.D.
CEO & Director
Dr. Michael J. Newman Ph.D.
Founder, Chief Scientific Officer & Director
Mr. Walt Addison Linscott Esq.
Chief Operating Officer
Dr. Roger J. Waltzman M.B.A., M.D.
Chief Medical Officer
Mr. Nir Sassi
CFO, Secretary & Treasurer

Important FAQs about investing in INDP Stock from India :

What is Indaptus Therapeutics share price today?

Indaptus Therapeutics share price today stands at $0.81, Open: $0.82 ; Previous Close: $0.82 ; High: $0.83 ; Low: $0.81 ; 52 Week High: $3.10 ; 52 Week Low: $0.70.

The stock opens at $0.82, after a previous close of $0.82. The stock reached a daily high of $0.83 and a low of $0.81, with a 52-week high of $3.10 and a 52-week low of $0.70.

Can Indians buy Indaptus Therapeutics shares?

Yes, Indians can invest in the Indaptus Therapeutics (INDP) from India.

With INDmoney, you can buy Indaptus Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Indaptus Therapeutics at zero transaction cost.

How can I buy Indaptus Therapeutics shares from India?

It is very easy to buy Indaptus Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Indaptus Therapeutics (INDP) be purchased?

Yes, you can buy fractional shares of Indaptus Therapeutics with INDmoney app.

What are the documents required to start investing in Indaptus Therapeutics stocks?

To start investing in Indaptus Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Indaptus Therapeutics Stock (INDP)?

Today’s highest price of Indaptus Therapeutics (INDP) is $0.83.

Today’s lowest price of Indaptus Therapeutics (INDP) is $0.81.

What is today's market capitalisation of Indaptus Therapeutics?

Today's market capitalisation of Indaptus Therapeutics INDP is 11.6M

What is the 52 Week High and Low Range of Indaptus Therapeutics Stock (INDP)?

  • 52 Week High

    $3.10

  • 52 Week Low

    $0.70

What are the historical returns of Indaptus Therapeutics (INDP)?

  • 1 Month Returns

    -11.45%

  • 3 Months Returns

    -46.23%

  • 1 Year Returns

    -58.36%

  • 5 Years Returns

    -95.79%

Who is the Chief Executive Officer (CEO) of Indaptus Therapeutics ?

Mr. Jeffrey A. Meckler J.D. is the current Chief Executive Officer (CEO) of Indaptus Therapeutics.

Discover More